PINNA, ANNALISA
PINNA, ANNALISA
Istituto di Neuroscienze - IN -
Characterization of Nasco grape pomace-loaded nutriosomes and their neuroprotective effects in the MPTP mouse model of Parkinson's disease
2022 Parekh P.; Serra M.; Allaw M.; Perra M.; Marongiu J.; Tolle G.; Pinna A.; Casu M.A.; Manconi M.; Caboni P.; Manzoni O.J.J.; Morelli M.
Influence of Age and Genetic Background on Ethanol Intake and Behavioral Response Following Ethanol Consumption and During Abstinence in a Model of Alcohol Abuse
2022 Corongiu, Silvia; Dessi, Christian; Espa, Elena; Pisanu, Augusta; Pinna, Annalisa; Lecca, Daniele; Fenu, Sandro; Cadoni, Cristina
Genes implicated in familial parkinson's disease provide a dual picture of nigral dopaminergic neurodegeneration with mitochondria taking center stage
2021 Franco, Rafael; RivasSantisteban, Rafael; Navarro, Gemma; Pinna, Annalisa; ReyesResina, Irene
Involvement of the protein ras homolog enriched in the striatum, rhes, in dopaminergic neurons' degeneration: Link to parkinson's disease
2021 Serra, Marcello; Pinna, Annalisa; Costa, Giulia; Usiello, Alessandro; Pasqualetti, Massimo; Avallone, Luigi; Morelli, Micaela; Napolitano, Francesco
Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor agonist and A2A receptor antagonist
2021 Pinna, Annalisa; Costa, Giulia; Serra, Marcello; Contu, Liliana; Morelli, Micaela
Protective Agents in Parkinson's Disease: Caffeine and Adenosine A2A Receptor Antagonists
2021 Simola, Nicola; Pinna, Annalisa; Frau, Lucia; Costa, Giulia; Marongiu, Jacopo; Parekh, Pathik; Serrai, Marcello; Morelli, Micaela Morelli
Gender Differences in Neurodegeneration, Neuroinflammation and Na+-Ca2+ Exchangers in the Female A53T Transgenic Mouse Model of Parkinson's Disease
2020 Costa G.; Sisalli M.J.; Simola N.; Della Notte S.; Casu M.A.; Serra M.; Pinna A.; Feliciello A.; Annunziato L.; Scorziello A.; Morelli M.
Pharmacological interactions between adenosine A2A receptor antagonists and different neurotransmitter systems
2020 Pinna, Annalisa; Serra, Marcello; Marongiu, Jacopo; Morelli, Micaela
Combined administration of dopaminergic and nondopaminergic drugs reverses neuroinflammation in a rat model of parkinson's disease
2019 Costa, G.; Serra, M.; Morelli, M.; Pinna, A.
Fos expression induced by olanzapine and risperidone in the central extended amygdala
2019 Pinna, A; Costa, G; Contu, L; Morelli, M
Lack of rhes increases mdma-induced neuroinflammation and dopamine neuron degeneration: Role of gender and age
2019 Costa G.; Porceddu P.F.; Serra M.; Casu M.A.; Schiano V.; Napolitano F.; Pinna A.; Usiello A.; Morelli M.
Neurofarmacologia nel trattamento della Malattia di Parkinson e nuovi approcci farmacologici
2019 Pinna, Annalisa; Morelli, Micaela
Neuroinflammation and activation of Zif-268 in dyskinetic 6-OHDA-lesioned rats is counteracted by association of a 5-HT1A/1B receptor agonist and an A(2A) receptor antagonist
2019 Pinna, A; Costa, G; Serra, M; Morelli, M
Dopaminergic neurodegeneration in a rat model of long-term hyperglycemia: preferential degeneration of the nigrostriatal motor pathway
2018 Renaud J.; Bassareo V.; Beaulieu J.; Pinna A.; Schlich M.; Lavoie C.; Murtas D.; Simola N.; Martinoli M.G.
NCX1 and NCX3 as potential factors contributing to neurodegeneration and neuroinflammation in the A53T transgenic mouse model of Parkinson's Disease article
2018 Sirabella, R; Sisalli, Mj; Costa, G; Omura, K; Ianniello, G; Pinna, A; Morelli, M; Di Renzo, Gm; Annunziato, L; Scorziello, A
Rhes counteracts dopamine neuron degeneration and neuroinflammation depending on gender and age
2018 Costa G.; Pinna A.; Porceddu P.F.; Casu M.A.; Di Maio A.; Napolitano F.; Usiello A.; Morelli M.
Role of adenosine A(2A) receptors in motor control: relevance to Parkinson's disease and dyskinesia
2018 Pinna, A; Serra, M; Morelli, M; Simola, N
A novel therapeutic strategy for the prevention of the onset of dyskinesia in the therapy of Parkinson's disease
2017 Pinna A; Costa G; Contu L; Serra M; Simola N; Carta M; Morelli M.
A novel therapeutic strategy to prevent the onset of dyskinesia in models of Parkinson's disease: acute and chronic studies.
2017 Pinna A; Costa G; Contu L; Serra M; Simola N; Carta M; Morelli M;.
Control of Motor Function by Adenosine A2A Receptors in Parkinson's and Huntington's Disease
2017 Pinna, A; Wardas, J; Domenici, Mr; Popoli, P; Cossu, G; Morelli, M